Clinical Trial Update: Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating a combination of chemotherapy, Interleukin-2, and peripheral stem cell transplant for acute myeloid leukemia, sponsored by EOR…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Interleukin-2 (interleukin-2)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Leukemia | Phase 3 | Status: UNKNOWN